Evolent Health, Inc. Revenue From Contract With Customer Excluding Assessed Tax

• Evolent Health, Inc. showed a decrease of -26.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
• This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Evolent Health, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 638.1%.
• Historical annual values: Fiscal year 2025: $1.88 billion | Fiscal year 2024: $2.55 billion | Fiscal year 2023: $1.96 billion | Fiscal year 2022: $1.35 billion | Fiscal year 2021: $907.96 million | Fiscal year 2020: $924.64 million | Fiscal year 2019: $846.38 million | Fiscal year 2018: $627.06 million | Fiscal year 2017: $434.95 million | Fiscal year 2016: $254.19 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026